Evidence map›Paper›PMID 42468528›Full record

ArticleImmunity2026

Autophagy maintains high endothelial venule identity and function during inflammation.

Kathryn A Jacobs, Yichao Hua, Apostolos Panagiotis Nikolakopoulos, Swati Gupta, Gerlanda Vella, Ana Filipa Domingues Laranjeiro, Julie Bonnereau, Mélanie Guyot, Maria Livia Sassano, Larissa Mourao and 11 more

Abstract read
In one paragraph

Article in Immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kathryn A JacobsLaboratory of Tumor Microenvironment and Therapeutic Resistance, Department of Oncology, KU Leuven, Leuven 3000, Belgium; Cell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium. Electronic address: kathryn.jacobs@kuleuven.be.
Yichao HuaLaboratory of Tumor Microenvironment and Therapeutic Resistance, Department of Oncology, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium; Department of Applied Computational Cancer Research, Institute for AI in Medicine (IKIM), University Hospital Essen, Essen 45147, Germany.
Apostolos Panagiotis NikolakopoulosCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium; Laboratory of Intravital Microscopy and Dynamics of Tumor Progression, Department of Oncology, KU Leuven, Leuven 3000, Belgium.
Swati GuptaLaboratory of Tumor Microenvironment and Therapeutic Resistance, Department of Oncology, KU Leuven, Leuven 3000, Belgium; Cell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium; Laboratory of Intravital Microscopy and Dynamics of Tumor Progression, Department of Oncology, KU Leuven, Leuven 3000, Belgium.
Gerlanda VellaLaboratory of Tumor Microenvironment and Therapeutic Resistance, Department of Oncology, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium.
Ana Filipa Domingues LaranjeiroLaboratory of Tumor Microenvironment and Therapeutic Resistance, Department of Oncology, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium.
Julie BonnereauCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium.
Mélanie GuyotLaboratory of Tumor Microenvironment and Therapeutic Resistance, Department of Oncology, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium.
Maria Livia SassanoCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium; VIB Center for Brain and Disease Research, Leuven 3000, Belgium.
Larissa MouraoVIB Center for Cancer Biology Research, Leuven 3000, Belgium; Laboratory of Intravital Microscopy and Dynamics of Tumor Progression, Department of Oncology, KU Leuven, Leuven 3000, Belgium.
Feyza CansizDepartment of Dermatology, University Hospital Essen & German Cancer Consortium, Essen 45147, Germany.
Gabriele AlliesDepartment of Dermatology, University Hospital Essen & German Cancer Consortium, Essen 45147, Germany.
Nicolas Van BarenInstitut de Duve, 1200 Brussels, Belgium.
Sophie LucasInstitut de Duve, 1200 Brussels, Belgium.
Hiroto KawashimaLaboratory of Microbiology and Immunology, Chiba University, Chiba 260-8675, Japan.
Wiebke SondermannDepartment of Dermatology, University Hospital Essen & German Cancer Consortium, Essen 45147, Germany; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen 91054, Germany.
Florian RambowDepartment of Applied Computational Cancer Research, Institute for AI in Medicine (IKIM), University Hospital Essen, Essen 45147, Germany.
Alpaslan TasdoganDepartment of Dermatology, University Hospital Essen & German Cancer Consortium, Essen 45147, Germany.
Colinda ScheeleVIB Center for Cancer Biology Research, Leuven 3000, Belgium; Laboratory of Intravital Microscopy and Dynamics of Tumor Progression, Department of Oncology, KU Leuven, Leuven 3000, Belgium.
Patrizia AgostinisCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium.
Gabriele BergersLaboratory of Tumor Microenvironment and Therapeutic Resistance, Department of Oncology, KU Leuven, Leuven 3000, Belgium; VIB Center for Cancer Biology Research, Leuven 3000, Belgium. Electronic address: gabriele.bergers@kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High endothelial venules (HEVs) play a crucial role in adaptive immune responses in secondary lymphoid organs (SLOs). They are equipped with high amounts of peripheral node addressin (PNAd), harboring carbohydrate structures that serve as L-selectin ligands to efficiently facilitate lymphocyte homing. During inflammation, the HEV network expands in SLOs, increasing lymphocyte infiltration, but the underlying mechanisms that maintain HEVs remain underexplored. Here, we report that autophagy is essential for HEV function and expansion. Using single-cell transcriptomics, unbiased proteomics, intravital imaging, and an inducible HEV tracer system in mice, we demonstrate that autophagy deficiency compromises lymphotoxin beta receptor (LTβR) signaling and the unfolded protein response in HEVs, leading to disrupted PNAd production, dedifferentiation, and reduced lymphocyte homing. Autophagy deficiency and LTβR blockade impair HEV function and reduce skin inflammation in psoriasis-affected mice by limiting immune infiltration and cytokine release. Our work reveals that autophagy safeguards HEV identity and function during inflammation.

Indexed as

AutophagyInflammationAnimalsAntigens, SurfaceLymphocytesLymphotoxin beta ReceptorMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMucoproteinsSignal TransductionUnfolded Protein ResponseVenulesAntigens, SurfaceL-selectin counter-receptorsLtbr protein, mouseLymphotoxin beta ReceptorMembrane ProteinsMucoproteinsautophagyHEVhigh endothelial venulesinflammationlymph nodelymphotoxin-beta receptorperipheral node addressinpsoriasisunfolded protein responseUPR

Identifiers

PMID42468528
PMCPMC13574368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.